«

»

Feb 13

An Important day is coming up

 

 BREAST CANCER: DRUGS FUNDING & TRIALS

Achieving world-class patient outcomes

 pic 1

A Pink Ribbon event Thursday 23 March 2017,

 9-5. Faculty of Pharmaceutical Medicine, London EC1V

 Gerard Dugdill, publisher/coordinator Pink Ribbon is the organiser of this crucial Breast Cancer event.

 Dr Kathleen Thompson, Frost Magazine’s health correspondent and award winning author of From Both Ends of the Stethoscope, will be chairing this event.

 Theme of the Day:

To identify issues and discuss potential solutions around achieving best care and treatment for all patients with breast cancer (primary and secondary) in UK, including enhancing options for research into curative treatments for secondary breast cancer.

 Although within the UK, generally, treatment of Breast Cancer is good, nevertheless the best possible treatment is not available to every patient with breast cancer who would benefit, within an optimal time-frame, for various reasons which will be discussed through the day.

In addition there is the general problem that secondary breast cancer is incurable currently. The purpose of the day is to explore how current initiatives, together with new unexplored initiatives can be implemented to maximise quality of treatment and cure for breast cancer within UK (and beyond, but the purpose of the day is primarily UK).

 Suitable for:

Top level movers and shakers and opinion formers in healthcare, regulation, industry, politics, academia, media, third sector

Attendees also include doctors, senior nurses, hospital administrators, other pharma personnel, researchers, civil servants, financiers, economists, lawyers, campaigners, media

 Sessions will range from The Problems – patient perspectives, System perspectives before moving on to the Solutions – Drug Development – Regulation – Funding -Keynote.

This is
 A Pink Ribbon event, in aid of the national hereditary breast cancer helpline

Supported by Pfizer Limited

To book, and for more information: https://goo.gl/3FExaS